Novartis Investigative Site

Ibaraki 305-8576

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Renal Cell, Lymphoma, Follicular, Neoplasms, Breast

Studies at this site

• Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma — Completed
• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy — Stopped early